Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine. 1992

H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
Third Department of Internal Medicine, School of Medicine, University of The Ryukyus, Okinawa, Japan.

An enhanced renal vasoconstrictive response to emotional stress may be related to the pathogenesis of essential hypertension. We examined the effects of chronic manidipine treatment on renal blood flow (RBF) responses to air jet stress, angiotensin II (ANG II), and endothelin-3 (ET-3) in the conscious unrestrained spontaneously hypertensive rat (SHR). Male SHRs were placed on a control diet or one containing 0.05% of manidipine for 4 weeks. Age-matched Wistar-Kyoto (WKY) rats placed on a control diet served as normotensive controls. In comparison with control SHRs, manidipine reduced blood pressure (p < 0.01), increased urinary sodium excretion (p < 0.01), and reduced body weight (p < 0.01). Air jet stress elevated arterial pressure and increased RBF. The pressor response was enhanced more in the control SHRs than in the WKY rats (p < 0.01) and was not altered by manidipine. The percent fall in RBF in the manidipine-treated SHRs (-16%) was less than that in the control SHRs (-30%, p < 0.05) and similar to that in the WKY rats (-18%). In contrast, the pressor effect and the percent fall in RBF caused by ANG II (0.1 nmol/kg/min) were similar in the three groups. Intravenous ET-3 (1 nmol/kg) caused a transient fall, followed by a sustained increase in systemic blood pressure, both of which were associated with a decrease in RBF. The RBF response to ET-3 was blunted in SHRs compared to WKYs and was not altered by manidipine treatment. These results suggest that antihypertensive therapy with manidipine may be beneficial in maintaining RBF during emotional stress.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D009578 Nitrobenzenes BENZENE derivatives carrying nitro group substituents.
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats

Related Publications

H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
December 1992, Journal of cardiovascular pharmacology,
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
July 1994, Hypertension (Dallas, Tex. : 1979),
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
September 1971, Acta physiologica Scandinavica,
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
December 1970, Acta physiologica Scandinavica,
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
March 2001, Hypertension (Dallas, Tex. : 1979),
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
June 1998, Journal of cardiovascular pharmacology,
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
July 1991, The Journal of pharmacology and experimental therapeutics,
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
March 1984, The Journal of pharmacy and pharmacology,
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
July 1997, Clinical and experimental pharmacology & physiology,
H Muratani, and S Takishita, and N Kawazoe, and M Tozawa, and K Fukiyama
January 1992, Blood pressure. Supplement,
Copied contents to your clipboard!